Iwao Kukimoto

No ORCID on file · 1 paper in corpus
diagnostic-accuracy 2024
Cancer science ·doi:10.1111/cas.16214

Currently, human papillomavirus tests and cytology are used to screen for cervical cancer. However, more accurate ancillary screening tests are needed. MicroRNAs (miRNAs) and cytokines are promising biomarkers that are aberrantly expressed …